NovaBay Pharma (NBY) Reports Prelim Q2 Revenue of $2.4M
Go back to NovaBay Pharma (NBY) Reports Prelim Q2 Revenue of $2.4M| NOVABAY PHARMACEUTICALS, Inc. (NYSE: NBY) | Delayed: 1.95 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.95 | 52 Week High | $5.29 | |||
| Open | $1.95 | 52 Week Low | $0.07 | |||
| Day High | $1.95 | P/E | N/A | |||
| Day Low | $1.95 | EPS | $-0.24 | |||
| Volume | 116,767 | |||||
